BOXED WARNING Potent diuretic; excessive amounts can cause profound diuresis with water and electrolyte depletion — careful supervision and individualized dosing required
FDA dosing
Population
Start
Target
Max
Edema
Adults
0.5–2 mg QD
0.5–2 mg QD (single dose)
10 mg/day
Renal Contraindicated in anuria; discontinue if marked rise in BUN/creatinine or oliguria in progressive renal disease
Hepatic Keep dosage to a minimum in hepatic failure
If initial dose inadequate, a 2nd or 3rd dose may be given at 4–5 hour intervals up to max 10 mg/day
Instructions
Individualize dose with careful monitoring of response and electrolytes
Intermittent schedule (alternate days, or 3–4 days on with 1–2 day rest) recommended for continued edema control
Bumetanide:furosemide substitution ratio approximately 1:40
May be given IV/IM when oral not practical; switch to oral as soon as possible
Contraindications
Anuria
Hepatic coma or severe electrolyte depletion (until corrected)
Cautions
Profound diuresis with fluid/electrolyte depletion